Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Immune System Suppression × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Pain, Postoperative 1 Inflammatory Bowel Diseases 1 Immune System Suppression 1 Diverticulitis 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Breakthrough Pain 1

Interventions

Morphine 1 Dexmedetomidine 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03024957 2021-01-14

Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity

Assiut University

Phase 1/2 Unknown

Immune System Suppression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡